Celiac.comAntireticulin Antibodies Obsolete as Test for Celiac DiseaseCeliac.comCeliac.com 04/22/2013 – A recent study of celiac screening methods shows that testing for antireticulin antibodies (ARA) in patients with celiac disease is obsolete. The st…
Pharmacyclics completes enrollment in phase III Ibrutinib CLL studypharmabiz.com… planned 110 patients in the phase II single-arm study using ibrutinib in patients with mantle cell lymphoma (MCL) who progress after bortezomib therapy and have receive…
PCYC Completes RESONATE EnrollmentZacks.com… which is being conducted to evaluate ibrutinib in mantle cell lymphoma (MCL) patients whose disease has progressed even after having received Velcade (bortezomib) therapy and at least one prior Rituxan (ri…
|
Celltrion slides to third in race for Roche rituximab biosimilar with planned …
Financial Times Celltrion, (KOSDAQ: 068270) the South Korean biosimilars developer, now looks to be third in the race to develop a biosimilar version of Roche’s (VTX:ROG) blockbuster Rituxan/Mabthera (rituximab), after it has emerged it does not actually plan to start … Report: Don’t count Celltrion out of Rituxan biosim raceFierceBiotech |
Scientists Find Ethnicity is Linked to Antibodies – Infection Control TodayInfection Control TodayCracking the DNA code for a complex region of the human genome has helped 14 North American scientists, including five at Simon Fraser University, chart n…
Presage Biosciences Announces First Patient in Clinical Trial of CIVO(TM …Wall Street JournalThe trial will enroll up to 12 patients with either newly diagnosed lymphomas who have not yet received treatment or relapsed lymphoma previously treated wit…
CTV NewsScientists find ethnicity linked to antibodiesScience CodexCracking the DNA code for a complex region of the human genome has helped 14 North American scientists, including five at Simon Fraser University, chart new territory in immunity resear…
Early Lymphocyte Recovery Following Stem Cell Transplantation May Improve …The MDS BeaconAs part of the transplant, patients received a high-dose chemotherapy regimen including cytarabine (Cytosar-U), busulfan (Busulfex), cyclophosphamide (Cytoxan), …
Roche sees another Rituxan biosimilar bite the dustFierceBiotechSamsung Electronics and Teva Pharmaceutical ($TEVA) both bailed out on biosimilar versions of rituximab (MabThera/Rituxan) last year amid uncertainty in regulation of copycat biologics in …
TopNews New ZealandLink Discovered between Antibodies and Races: StudyTopNews New ZealandComplex DNA structure of the human genome has aided in immunity research. The researchers at Simon Fraser University have discovered a number of antibodies that ar…